Pharmaceutical and dietary composition

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514861, A61K 3123

Patent

active

048682128

ABSTRACT:
A method of treatment of atopic disorders, including eczema, asthma, allergies (especially allergic rhinitis), migraine and disorders associated with atopy including Crohn's disease, ulcerative colitis, otitis media, nephrotic syndrome, or benign breast disease, or breast or other cancer, or diabetes, or alcoholism, with effective amounts of one or more of the metabolites of linoleic acid (GLA, DGLA, AA, 22:4n-6 or 22:5n-6) and one or more of the metabolites of .alpha.-linolenic acid (18:4n-3, 20:4n-3, 20:5n-3, 22:5n-3 or 22:6n-3) are administered as such or in the form of an ester, salt, amide or other derivative convertible in the body thereto alone or in an acceptable pharmaceutical carrier or diluent.

REFERENCES:
patent: 4444755 (1984-04-01), Horrobin
patent: 4681896 (1987-07-01), Horrobin
Stedman's Medical Dictionary, 22 Edition.
Horrobin, Lancet, vol. 1, Jan. 31, 1981, p. 278.
Pharmaceutical Science, Mack Pub. Co., 1980, "Arachidanic Acid", p. 973.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical and dietary composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical and dietary composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical and dietary composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-369052

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.